Invitrogen Corporation (Invitrogen) is a developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The... more

Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

Stratagene is a developer, manufacturer and marketer of specialized life science research and diagnostic products. The Company's life science research unit supports advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research.... more

Alfacell Corporation is a biopharmaceutical company engaged in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions. The Company’s drug discovery and development program consists of therapeutics, which are being... more

Genencor is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable... more

Sirtris, a GlaxoSmithKline company, is developing small molecule drugs that target the sirtuins, a recently discovered family of seven enzymes associated with the aging process. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Founded in... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes'... more

QIAGEN N.V. (QIAGEN) is a provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. The Company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Products are sold to academic research... more

MethylGene Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for cancer. As of December 31, 2007, the Company is running multiple Phase I, Phase I/II, and Phase II clinical trials with its compound MGCD0103, an HDAC oncology... more

Biocon Limited (Biocon) is engaged in manufacturing biotechnological products in the pharmaceutical through fermentation-based technology, and is also engaged in the formulation business. In the biopharmaceuticals segment, it focuses on the manufacture and marketing of active... more

BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company that designs, optimizes and develops drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. It integrates the necessary disciplines of biology, crystallography, medicinal chemistry and... more

Maxygen, Inc. (Maxygen), incorporated on May 7, 1996, is a biotechnology company involved in the discovery and development of next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. As of December 31, 2007, the Company had three of its... more

Novo Nordisk A/S is a Denmark-based healthcare company. The Company provides diabetes care and has diabetes product portfolio in the industry, including insulin delivery systems. Novo Nordisk operates on a worldwide basis in two business segments: diabetes care, which includes discovery,... more

Pharmacopeia, Inc. is a clinical development stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics to address medical needs. It has a portfolio of clinical and preclinical candidates under development internally or by partners, including eight... more

Established in the 1970s, Iogen Corporation has become one of Canada's leading biotechnology firms. Iogen is the world leader in technology to produce cellulose ethanol, a fully renewable, advanced biofuel that can be used in today's cars. Iogen is also an industrial manufacturer of... more

BioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises three products and multiple investigational product candidates. Approved products include Naglazyme (galsulfase), Kuvan... more

Ventria Bioscience is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innovative, high value products that enhance and save lives. We have achieved scientific excellence through internal research and... more

diaDexus makes a difference by developing innovative products to detect cancer and cardiovascular disease.

Ambion RNA Diagnostics was created to provide RNA-based products and services to the in vitro diagnostic and pharmaceutical processing industries. Its state-of-the-art molecular biology laboratory is a cGMP multi-user, multi-product facility that includes fully equipped, process and... more

Athenix is a leader in agricultural and industrial biotechnology. We are a company of highly motivated, uniquely skilled people. We have rapidly built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs. Athenix is committed... more

Codexis is a leading developer of biocatalytic chemical processes that can dramatically reduce manufacturing costs across a broad range of industries. Our proprietary technology enables novel solutions for cost-effective, efficient and environmentally sound production of pharmaceuticals,... more

Dyadic International, Inc. (Dyadic) is a global biotechnology company that uses its technologies (the Dyadic Platform Technology) to conduct research and development activities for the discovery, development, and manufacture of products and enabling solutions to the bioenergy, industrial... more

Diversa provides novel products to address a variety of animal care needs. Our products, Phyzymeâ„¢-XP enzyme, in partnership with Dansico, and Quantumâ„¢ phytase, in partnership with Syngenta, improve the nutritional value of feed for poultry and swine while reducing phosphate pollution.... more

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the drug delivery, oncology, and dermatology markets. Its portfolio of products is based on the property covering the family of... more

BiPar Sciences is a privately held biopharmaceutical company committed to creating a world-class drug development and commercialization organization that addresses significant unmet medical needs in oncology. Our lead product candidate is BSI-201, which is now in a Phase 1a trial as a... more

Cytochroma Inc. is a development stage specialty pharmaceutical company focused on the treatment and prevention of disorders related to Vitamin D insufficiency. The Company has a portfolio of therapeutics with lower development risk for the indications of Vitamin D insufficiency and for... more

OXIS International, Inc. (OXIS) focuses on the research and development of technologies and therapeutic products in the field of oxidative stress/inflammatory reaction, diseases that are associated with damage from free radicals and reactive oxygen species. Its products include... more

Promega Corporation is a global leader in providing innovative solutions for the life sciences industry. The company's 1,200 products enable scientists worldwide to advance knowledge in cellular analysis, proteomics, and genomics research with applications in drug discovery, molecular... more

SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. SGX's oncology pipeline includes drug candidates from its enabling, proprietary FASTÔ drug discovery platform, such... more

Progen Pharmaceuticals Limited (Progen) is an Australia-based company. During the fiscal year ended June 30, 2008 (fiscal 2008), the principal activities of the Company were discovery, research and development of biopharmaceutical therapeutics for the treatment of human diseases, and the... more

Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company markets one product, ReplagalÔ, for the treatment of Fabry disease in the European Union and other countries, and is developing... more

Xencor's employees are the most important factor in our success. We have assembled a highly talented group from diverse backgrounds and disciplines to execute our business plan and shape our future. Xencor employees value new ideas and flexibility and demand from each other scientific... more

Neose Technologies Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutic proteins. The Company has two therapeutic protein candidates in clinical trials, GlycoPEG-GCSF and GlycoPEG-FVIIa, and two therapeutic protein candidates in the research stage,... more

We are committed to improving therapy for cancer patients by building strong international collaborations to fully realize the potential of our products. On 31st Jan 2006, KuDOS was aquired and is now a wholly owned subsidiary of AstraZeneca.

Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including metabolic disease,... more

IBEX Technologies, Inc. (IBEX) is a biopharmaceutical company engaged in the production and sale of enzymes for use as reagents in hemostasis monitoring devices, and of arthritis diagnostic kits for pharmaceutical research. It is principally engaged in the production and sale of... more

Transgenomic, Inc. provides products for the synthesis, purification and analysis of nucleic acids used in the life sciences industry for research focused on molecular genetics and diagnostics. The Company also provides genetic variation analytical services to the medical research,... more

Founded in 1975, Molecular Probes is the leading worldwide provider of fluorescence-based detection solutions to advance scientific and biomedical research. Molecular Probes' research-driven strategy has produced an extensive product line that includes a wide range of fluorescent probes... more

GlycoDesign is currently developing ATH in preclinical studies as a therapeutic for the prevention of neurocognitive deficits during cardiopulmonary bypass surgery. The Company plans to partner with device companies to develop ATH as an antithrombotic coating on catheters used for... more

Founded in 1984, Clontech is located in Palo Alto, California, and has 330 employees worldwide. The Company offers over 1,800 products within 130 product lines that address scientists' needs in the areas of gene identification, gene expression analysis, functional analysis and target... more

Upstate is one of the world's leading developers and suppliers of cell signalling reagents, assays and screening services for the biopharmaceutical research and industrial communities.

Established in the mid-1970s as a cooperative laboratory of experienced scientists, New England Biolabs is a world leader in the production and supply of reagents for the life science industry. NEB now offers the largest selection of recombinant and native enzymes for genomic research and... more

Omeros Corporation is a clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company’s clinically advanced product candidates are derived from its PharmacoSurgerytm... more

Inotek Pharmaceuticals Corporation is a clinical-stage, drug development company with four distinct programs targeting fundamental mechanisms of cell injury, cell survival and inflammation. The Company has two Phase 1 programs, including a candidate for the treatment of glaucoma and a... more

Metaphore Pharmaceuticals, Inc. discovers and develops drugs for the treatment of diseases associated with free radical damage and inflammation. The company leverages its expertise in chemistry and biology to discover and develop small molecule compounds that mimic the activity of human... more

KAI Pharmaceuticals is a biology-based, product-driven, drug discovery and development company leveraging protein kinase C (PKC) signaling to generate a portfolio of clinical and preclinical drug candidates for the treatment of acute cardiovascular and other important human diseases. The... more

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME's principal focus has been on applying its proprietary AMEsystemÔ technology platform to... more

Paion AG is a biopharmaceutical holding company based in Aachen, Germany. It develops and commercializes drugs for the treatment of strokes and problems relating to the central nervous system, as well as other thrombotic diseases. Paion's core activity is the advancement of drug... more

Verenium Corporation possesses a portfolio of specialty enzyme products and is developing technical and operational capabilities designed to enable the production of low-cost, biomass-derived sugars for a number of industrial applications, including the commercialization of biofuels. The... more